GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Ryvu Therapeutics RVU.WA · PLN

Health Care · GPW · 🇵🇱 Poland

Compare

16.32

-0.73%

Close of 9 Nov 2026, in PLN

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

8 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 4Buy
  • 2Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Last close 16.32Average target 54.50

Low
29.29
Average
54.50
Median
32.64
High
104.27

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
RevenuePLN 122.1mPLN 218.0mPLN 124.5mPLN 27.0mPLN 107.0m
Revenue, highestPLN 173.3mPLN 338.2mPLN 140.3mPLN 38.9mPLN 154.0m
Revenue, lowestPLN 70.8mPLN 97.8mPLN 108.7mPLN 15.1mPLN 60.0m
Earnings per share-0.294.57-2.30——
Earnings per share, highest-0.2711.980.27——
Earnings per share, lowest-0.32-2.84-4.87——
Analysts22211

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

4 / 10

Revenue growth 4.3% a year over 10 years. Return on equity -188.0%.

Model fair value

30.94

From earnings 30.94, from revenue 51.37.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.